loncastuximab,lenalidomide,polatuzumab vedotin,axicabtagene ciloleucel,lisocabtagene maraleucel,vedolizumab,tafasitamab,selinexor
daiichi sankyo,karyopharm,i-mab,overland adct biopharmaceuticals,gilead,takeda,roche,mitsubishi tanabe,bms,incyte,morphosys
[' vedo', 'dlbcl', 'selinexor', 'lenalidomide', 'axi-cel', 'liso-cel', 'elevate,(-elevate uc),(-elevateuc),(-elevate-uc),(-elevate rr),(-elevaterr),(-elevate-rr),(-elevate tn),(-elevatetn),(-elevate-tn)', 'polatuzumab', ' lena', 'loncastuximab tesirine', 'tafasitamab', 'imab ']
#cartcell and novel therapies for #dlbcl #ash22 bendapola, tafalena interesting road ahead 
Microbiólogo y Médico @UniAndes, Internista @FSFB_salud, Hematólogo de @HematoCAUSA en @HHospitalet, Colaboro @ProyectoIdun #HSCT #Infections #CARTcells #GvHD